Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0598-2025

Cartiva Synthetic Cartilage Implant (SCI) Catalog: CAR-06-US (6mm), CAR-08-US (8mm), CAR-10-US (10mm), CAR-12-US (12mm) Recall

Cartiva Synthetic Cartilage Implant (SCI) Catalog: CAR-06-US (6mm), CAR-08-US (8mm), CAR-10-US (10mm), CAR-12-US (12mm)

FDA recall Class II

Ongoing

FDA lists this Class II recall for Cartiva Synthetic Cartilage Implant (SCI) Catalog: CAR-06-US (6mm), CAR-08-US (8mm), CAR-10-US (10mm), CAR-12-US (12mm). Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0598-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Oct 31, 2024
FDA report date
Dec 11, 2024
Quantity in commerce
Not reported
Distribution
See key details
FDA cause
Device Design

What is being recalled?

Cartiva Synthetic Cartilage Implant (SCI) Catalog: CAR-06-US (6mm), CAR-08-US (8mm), CAR-10-US (10mm), CAR-12-US (12mm)

Affected model & UDI checker

Search the exact identifiers published for Z-0598-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
CAR-06-USCartiva Synthetic Cartilage Implant (SCI) Catalog: CAR-06-US (6mm), CAR-08-US (8mm), CAR-10-US (10mm), CAR-12-US (12mm)Check source noticeNot specified
FDA code information

Catalog/UDI-DI: CAR-06-US/00852897002328, CAR-08-US/00852897002021, CAR-10-US/ 00852897002038, CAR-12-US/00852897002335. All lots Distributed from July 2016 to October 2024.

View the original FDA recall notice

Why was this product recalled?

Patients implanted with synthetic cartilage implant, may experience a higher-than expected occurrence rate of the following hazards: revision, removal, implant subsidence, displacement, pain, nerve damage or fragmentation.

What actions did Cartiva, Inc take?

On 10/31/24 recall notices were mailed or emailed to customers asking them to do the following: 1) Continue to follow patients treated with an impacted product for new or worsening symptoms of pain, difficulty walking, skin reactions, stiffness, swelling, or weakness of the big toe joint, consistent with your follow up protocols. Per Instructions for Use: the long-term effects of cartilage replacement are not known; and the clinical and medical status of each patient should be considered when treating patients. 2) To help minimize complications, reference the information in the Instructions for Use and the information included in this notification. Per standard practice, continue to discuss all potential risks identified and discuss the benefits and risks of all relevant treatment options for first metatarsophalangeal joint osteoarthritis with your patients. 3) Check your internal inventory to locate the products listed on the attached business reply form, remove them from their point of use, isolate/quarantine the unit(s), and return. 4) Share and maintain awareness of this communication in your practice with until all required actions have been completed within your facility. 5) If you have further distributed the affected product, please notify the applicable parties about this notice. You may copy and distribute this notification letter. 6) If possible, inform us if any of the subject devices have been distributed to other organizations, including contact details so that we can inform the recipients appropriately. 7) If you are a distributor, note that you are responsible for notifying your affected customers. 8) Complete and return the response form via email to fieldaction@stryker.com For questions or concerns, contact fieldaction@stryker.com.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology